...
The Skin May Just Be the Beginning: Pre-PsA and Clinical Clues of PsA in Patients with Psoriasis
November 18, 2021

Join Jane Mast PA-C, MPAS, DMSc, and Alexis Neal MBA, MS, PA-C, as they discuss Pre-Psoriatic Arthritis and Psoriatic Arthritis in Patients with Psoriasis. (Mast is a Regional Medical Director at Novartis, and Neal is the Dermatology Regional Medical Director for the Central Geography at Novartis.) The program is presented by Novartis Medical Affairs Watch

...
Motherhood & Medicine: You Can’t Have It All (All the time)
November 7, 2021

As a mom of five children and PA for 17 years, Bethany Grubb, MPH, MPAS, PA-C, came to her Saturday deeper dive session armed with years of experience balancing the role of mother and medical provider. PA Grubb discussed the work/life balance that many PAs struggle with – not to mention the added challenges caused

...
“What Bit Me?”
November 6, 2021

How to Recognize and Treat Bites Caused by Bed Bugs, Scabies, Body Lice and Other Pests Aileen Chang, MD, UCSF Assistant Professor of Dermatology and Director of Global Health Dermatology, highlighted ectoparasitosis in one of the “deeper dialogue” sessions held during the SDPA 19th Annual Fall Dermatology Conference in Los Angeles.  Dr. Chang reviewed her

...
A Closer Look at Physical Signs of Drug Abuse

Only 2% of Patients Get Their Medications from More Than One Medical Provider UT Southwest Assistant Professor and Physician, Rebecca Vasquez, MD, gave an enlightening discussion highlighting the cutaneous signs of substance abuse. While many medical providers are familiar with the term “doctor shoppers”, she reports that only 2% of patients get their medications from

...
Psoriasis and Biologics: Selecting the Right Biologic for the Right Patient
November 5, 2021

During the first afternoon lecture, Zelma Chiesa Fuxench, MD, MSCE, an assistant professor of dermatology at the University of Pennsylvania, reviewed the currently available biologic agents for psoriasis and how to select the “right” biologic for the “right” patient. She began the lecture reiterating that using the same biologic for all patients is not the